Literature DB >> 1909688

Bactericidal effect of penicillin, ampicillin, and amoxicillin alone and in combination with tobramycin against Enterococcus faecalis as determined by kill-kinetic studies.

H Westh1, N Frimodt-Møller, E Gutschik.   

Abstract

Fifteen strains of Enterococcus faecalis, all clinical blood culture isolates from patients with endocarditis, were studied by kill-kinetic experiments using penicillin G, ampicillin and amoxicillin alone and in combination with tobramycin. The median minimal inhibitory concentrations (MIC), were penicillin 4 mg/l, ampicillin 2 mg/l, amoxicillin 2 mg/l and tobramycin 32 mg/l. Equipotent doses of the antibiotics (1/2 x MIC, 1 x MIC and 4 x MIC) were used in the kill-kinetic studies. Synergism was studied using a combination of 1/2 x MIC of the beta-lactam antibiotic and 8 mg/l of tobramycin. The bactericidal activity did not exceed 10(+3) cfu/ml at 5 hours for any single compound. After 5 h all three beta-lactam antibiotics in combination with tobramycin resulted in synergism, i.e. more than one hundredfold reduction of colony forming units (cfu) as compared to the most active single agent. Amoxicillin had a significantly higher bactericidal potential than ampicillin or penicillin both alone and in combination with tobramycin. The clinical significance of these findings warrants further studies in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909688     DOI: 10.1007/bf01643244

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  13 in total

1.  Activity of amoxycillin, alone, and in combination with aminoglycoside antibiotics against streptococci associated with bacterial endocarditis.

Authors:  M J Basker; R Sutherland
Journal:  J Antimicrob Chemother       Date:  1977-05       Impact factor: 5.790

2.  Laboratory evaluation of amoxicillin.

Authors:  G N Rolinson
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

3.  Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center.

Authors:  G L Mandell; D Kaye; M E Levison; E W Hook
Journal:  Arch Intern Med       Date:  1970-02

4.  Comparative effects of amoxycillin and ampicillin in the treatment of experimental mouse infections.

Authors:  K R Comber; C D Osborne; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

5.  A comparison of the in-vitro activity of seventeen antibiotics against Streptococcus faecalis.

Authors:  J L Pérez; L Riera; F Valls; C I Berrocal; L Berrocal
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

6.  The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms.

Authors:  H EAGLE; A D MUSSELMAN
Journal:  J Exp Med       Date:  1948-07       Impact factor: 14.307

7.  In vitro antibacterial activities of eleven antibiotics against S. faecalis.

Authors:  S H Hartzen; N Frimodt-Möller; J J Andreasen
Journal:  APMIS       Date:  1988-07       Impact factor: 3.205

8.  Enterococcal endocarditis.

Authors:  C J Wilkowske
Journal:  Mayo Clin Proc       Date:  1982-02       Impact factor: 7.616

9.  Penicillin-tobramycin synergism against enterococci: a comparison with penicillin and gentamicin.

Authors:  R C Moellering; C Wennersten; A J Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

10.  Effect of combinations of penicillin and aminoglycosides on Streptococcus faecalis: a comparative study of seven aminoglycoside antibiotics.

Authors:  E Gutschik; O B Jepsen; I Mortensen
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

View more
  2 in total

1.  In Vivo and In Vitro Effects of a ClpP-Activating Antibiotic against Vancomycin-Resistant Enterococci.

Authors:  Autumn Brown Gandt; Elizabeth C Griffith; Ida M Lister; Lisa L Billings; Angel Han; Rajendra Tangallapally; Ying Zhao; Aman P Singh; Richard E Lee; Michael D LaFleur
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

2.  A clinical and in vitro assessment of outpatient parenteral benzylpenicillin and ceftriaxone combination therapy for enterococcal endovascular infections.

Authors:  Paul R Ingram; Jacinta Ng; Claire Mathieson; Shakeel Mowlaboccus; Geoffrey Coombs; Edward Raby; John Dyer
Journal:  JAC Antimicrob Resist       Date:  2021-08-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.